Despite high specificity, the tests show low sensitivity for early-stage cancers, necessitating further validation through ...

Guardant Health has a trailing 12 month Price to Earnings (P/E) ratio of -13.4 while the S&P 500 average is 29.3 Its forward ...

Further assay results have been released by PTX Metals (TSXV: PTX) related to a phase 1 drill program conducted at their W2 ...

Multicancer early detection (MCED) assays use circulating tumor DNA, methylation patterns, RNA, and protein biomarkers to detect multiple cancer types early, potentially revolutionizing cancer ...

Nova Pacific Metals Corp. (CSE: NVPC) (OTCQB: NVPCF) (FSE: YQ10) (WKN: A40GFH) (the "Company", or "Nova Pacific") is pleased ...

Hayasa has contracted AT Group , a drilling company based in Yerevan, Armenia which has worked with the Company in the past.

A new study shows how person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) strains dominate in a population.

Qiagen N.V. (NYSE: QGEN) has announced two strategic partnerships designed to revolutionize minimal residual disease (MRD) ...

Personalis, Inc. (NASDAQ: PSNL) has unveiled breakthrough clinical data showing its NeXT Personal ctDNA blood test can ...

ASX-listed Alchemy Resources has acquired full ownership of the iron-ore rights at its Bryah project in Western Australia, buying out joint venture partner Carey Mining for A$75 000 and a ...

The acquisition of biocrates further enhances Bruker's MS-based metabolomics solutions. It also supports Bruker's expansion ...